Detalles de la búsqueda
1.
The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial.
J Card Fail;
28(5): 778-786, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34933097
2.
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.
Eur Heart J;
42(6): 684-696, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33215209
3.
Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial.
Cardiovasc Diabetol;
20(1): 163, 2021 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34372849
4.
Declining Risk of Sudden Death in Heart Failure.
N Engl J Med;
377(18): 1793-4, 2017 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29094860
5.
Trials of Patent Foramen Ovale Closure.
N Engl J Med;
377(26): 2598-2599, 2017 12 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29281581
6.
[Shared decision-making in metaclinical medicine: from informed consent to shared probability]. / Il processo decisionale condiviso nella medicina metaclinica: dal consenso informato alla probabilità condivisa.
G Ital Cardiol (Rome);
25(4): 221-228, 2024 Apr.
Artículo
en Italiano
| MEDLINE | ID: mdl-38526358
7.
Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial.
ESC Heart Fail;
11(1): 209-218, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37939716
8.
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial.
Heart;
2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729636
9.
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials.
Eur J Heart Fail;
25(1): 108-113, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36303266
10.
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.
Int J Cardiol;
377: 86-88, 2023 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36738846
11.
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study.
Circ Heart Fail;
16(5): e009694, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37192292
12.
[Process to insulin for type 2 diabetes mellitus therapy]. / Processo all'insulina nella terapia del diabete mellito di tipo 2.
G Ital Cardiol (Rome);
23(1): 52-62, 2022 Jan.
Artículo
en Italiano
| MEDLINE | ID: mdl-34985463
13.
The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
Eur J Heart Fail;
24(9): 1559-1568, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35703355
14.
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial.
Eur J Heart Fail;
24(5): 771-778, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35199421
15.
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial.
Eur Heart J Cardiovasc Pharmacother;
8(2): 149-156, 2022 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33822033
16.
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.
Eur J Heart Fail;
24(2): 321-331, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34841615
17.
Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial.
ESC Heart Fail;
9(6): 4352-4357, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36065795
18.
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF.
JACC Heart Fail;
9(4): 268-277, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33549556
19.
[The patient in clinical research: disposable guinea pig or involved actor?] / Il paziente nella ricerca clinica: cavia a disposizione o attore interessato?
G Ital Cardiol (Rome);
21(4): 309-314, 2020 Apr.
Artículo
en Italiano
| MEDLINE | ID: mdl-32202565
20.
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial.
Eur J Heart Fail;
22(9): 1711-1723, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31950604